Plus Therapeutics (PSTV) Misses Q3 EPS by 4c

Plus Therapeutics (NASDAQ: PSTV) reported Q3 EPS of ($0.04). Revenue for the quarter came in at $1.4 million.

For earnings history and earnings-related data on Plus Therapeutics (PSTV) click here.

You May Also Be Interested In

• Dingdong (DDL) Reports Q2 EPS of RMB0.90
• Robo.ai completes acquisitions, plans interim report for Aug. 24
• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance